The weekly litigation news digest is live. Subscribe now

IP Verse

Composition Containing Apomorphine And A Divalent Metal Cation - EP3174526

The patent EP3174526 was granted to Britannia Pharmaceuticals on Mar 22, 2023. The application was originally filed on Jul 31, 2015 under application number EP15766745A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3174526

BRITANNIA PHARMACEUTICALS
Application Number
EP15766745A
Filing Date
Jul 31, 2015
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EVER NEURO PHARMAJun 10, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB -

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS6514482
INTERNATIONAL-SEARCH-REPORTEP2545905
INTERNATIONAL-SEARCH-REPORTUS2011111011
OPPOSITIONEP2545905
OPPOSITIONUS2011111011

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents